Zim Laboratories Ltd (NSE:ZIMLAB)

Q3 2026 ZIM Laboratories Ltd Earnings Call Transcript

Feb 12, 2026 / 04:30 AM GMT

Release Date Price: ₹71.23 (-4.80%)

Transcript

Key Points

Positve

Zim Laboratories Ltd (BOM:541400) reported a total operating income of approximately INR 1,087 million, reflecting improvement both sequentially and year-over-year.
The export business increased significantly in Q3 FY26 to INR 90,600 million, an increase of 23.2% year-over-year, contributing 88% to the total operating income.
The company completed a preferential issue raising approximately INR 35 crore, which will be used for expansion and regulatory compliance initiatives.
Senior leadership additions were made during the quarter, strengthening the company's capabilities in international business, quality assurance, and human resources.
Zim Laboratories Ltd (BOM:541400) remains optimistic about closing the financial year on a stronger note, focusing on long-term growth platforms and business continuity.

Negative

The company is facing regulatory challenges with its EGMP certification, which is critical for unlocking value in regulated markets.
Margins remained under pressure on a 9-month basis due to higher operating expenses and continued investment towards regulatory and compliance initiatives.
There is uncertainty regarding the timeline for the commercialization of NIB and ODF products in the European market due to ongoing regulatory issues.
The preferential issue raised concerns among investors about the dilution of shares and the price at which it was conducted.
The company is undertaking site transfers for some products to mitigate risks, which may have a nominal impact on margins.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ZIML.NS - Zim Laboratories Ltd
Q3 2026 ZIM Laboratories Ltd Earnings Call
Feb 13, 2026 / 04:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Morning ladies and gentlemen. I'm Akash, moderator for the conference call. Welcome to Zim Laboratories Limited Q3 and 91 FY26 earnings conference call.

As a reminder, all participants will be in listen-only mode, and there'll be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an operator by pressing, then 0 on your touchstone telephone.

Please note this conference is recorded. I would now like to hand over the floor to Ms. Deepika Sharma from Go India Advisors.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.